Bone Densitometers Market is Expected to Reach USD 908.5 Million Globally in 2019

Bone Densitometers Market (DEXA, QCT, pDEXA, SEXA, pQCT, RA and QUS)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

bone

The global bone densitometers market was valued at USD 777.9 million in 2012 and is expected to grow at a CAGR of 3.3% from 2013 to 2019, to reach an estimated value of USD 908.5million in 2019.

Bone densitometry is a non-invasive diagnostic technique which involves use of bone densitometers for quantitative measurement of bone mass or density. Over a past few decades, decrease in bone mass or density has been associated with the occurrence of fractures in future and thus bone density measurement has been considered as an indicator to predict fracture risk. Moreover, people with medications for corticosteroid treatment, cancer, eating disorders, amenorrhea and genetic disorders are also preferred for evaluation of bone mineral density.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/bone-densitometers-market.html

Major improvements in diagnostic technology have been witnessed since last decade due to change in perception for osteoporotic disease, growing elderly population and high expenditure to society and healthcare agencies along with the adverse effects on patients across the globe. The advances in the technology are making it possible for early detection of disease before fracture occurs. With socio-economic development in many developing countries and rapid ageing of the population, osteoporosis has become one of the most prevalent and costly health problems in these regions. Growing ageing population combined with increased vitamin D deficient patients and rise in risk for osteoporosis in post-menopausal women contribute to the growth of this market particularly in emerging economies of Middle East, India, China and Japan. Moreover, technological advances in bone densitometerscoupled with increase in access and recognition of these technologies in emerging market, such as China, Brazil, Japan and India will serve as an opportunity for investors to invest in.

The global market for bone densitometers has been studied from the perspective of currently widely accepted technologies and the major end users. Technologies are further segmented, based on axial and peripheral bone density measurement. Axial bone densitometers include dual energy X-ray absorptiometry and quantitative computed tomography. Peripheral bone densitometers include single energy X-ray absorptiometry, peripheral dual energy X-ray absorptiometry, radiographic absorptiometry, quantitative ultrasound and peripheral computed tomography. The endusers for bone densitometers include clinics and hospitals.Hospitals remain the major hub in most of the countries across the globe for bone densitometry diagnostics and devices.

Browse the full report PDF with TOC : Bone Densitometers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

It is expected that the global market for axial bone densitometers will grow at a CAGR of over 3% from 2013 to 2019.In 2012, axial DEXA accounted for the largest share by revenue at USD 297.8 million of the total bone densitometers market. However, due to thedecrease in the reimbursement, the overall market revenue is expected to decline during the forecast period in the U.S and Europe.The market for axial QCTaccounted for the second largest share at USD 182.9million, in 2012. Moreover, it is expected that the global market for peripheral QCT bone densitometers will grow at a CAGR of over 4% from 2013 to 2019, owing to its high sensitivity, portability of devices, lesser scanning time, with better precision and accuracy, and also less radiation exposure.

Geographically, North America dominatedthe global market for bone densitometersin terms of revenue generation and is expected to maintain its position throughout the forecast period. Theadoption of DEXA systems, growing elderly population and consequent rise in incidences of osteoporosis in the U.S., is expected to contribute to the leadership of the North American market. Europe was the second largest regional market for bone densitometersin 2012, owing to the increased demand for bone density measurement.

The global bone densitometers market is dominated by few major players includingGE Healthcare Ltd.,Hologic, Inc., CooperSurgical, Inc. and Diagnostic Medical Systems S.A. Theother key players in the bone densitometers marketinclude BeamMed Ltd.,CompuMed, Inc., Lone Oak Medical Technologies LLC and OsteometerMediTech, Inc.

The global bone densitometers market is segmented as follows:

Bone Densitometers Market, by Technology

  • Axial Bone Densitometers
    • Dual Energy X-Ray Absorptiometry (DEXA)
    • Quantitative Computed Tomography (QCT)
  • Peripheral Bone Densitometers
    • X-ray Absorptiometry
      • Peripheral Dual energy X-ray Absorptiometry (pDEXA)
      • Single Energy X-Ray Absorptiometry (SEXA)
    • Radiographic Absorptiometry (RA)
    • Quantitative Ultrasound (QUS)
    • Peripheral Quantitative Computed Tomography (pQCT)

Bone Densitometers Market, by End-users

  • Clinics
  • Hospitals

Bone Densitometers Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/

Polypropylene Market Will Reach USD 124.01 Billion by 2019, Growing at a CAGR Of 6.3% From 2013 to 2019.

Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Defibrillators

Transparency Market Research Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators)Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019, the global defibrillators market was valued at USD 9.3 billion in 2012 and is expected to grow at a CAGR of 6.2% from 2013 to 2019, to reach an estimated value of USD 14.2billion in 2019.

Browse Global Defibrillators Market Report with Full TOC at http://www.transparencymarketresearch.com/defibrillators-market.html

Defibrillator devices are used to treat life-threatening cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. These devices provide an electrical shock, having energy 40 – 400 Joule, to the heart muscles which terminates the arrhythmia and restores the normal sinus rhythm in the heart. Since the defibrillator devices are very useful in preventing deaths due to sudden cardiac arrest (SCA), the large number of SCA incidences across the globe is the major driver for the growth of this market.

Growing incidences of cardiovascular diseases and disorders combined with aging of baby boomer population in the U.S. are contributing to the growth of the global defibrillators market.Furthermore, the market is more driven by demand from emerging countries from Asia-Pacific and the Middle-East. Increasing trend towards installations of AEDs at workplaces by businesses is expected to serve as a good opportunity for the growth of global defibrillators market.

Defibrillators Market

The global defibrillators market has been segmented on the basis of product types, end-users and geographic regions. On the basis of defibrillator types, the market is divided into advanced life support (ALS) defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs) and wearable defibrillators. In 2012, implantable defibrillator devices accounted for the largest share by revenue of the global defibrillators followed by ALS defibrillators.The global rise in the healthcare infrastructure which include state-of-the-art hospitals and ambulances equipped with advanced medical devices is seen as a driver for ALS defibrillator segment.

Browse the full report PDF with TOC : Defibrillators Market is Expected to Reach USD 14.2 Billion Globally in 2019 Transparency Market Research

The report also provides market estimations for the end-users of defibrillator devices during the forecast period of 2013 to 2019. The market has been categorized on the basis of end-users into five major segments, namely, hospitals, home, public access, emergency medical services and business workplace. In 2012, the hospitals as an end-user category shared more than 90%of the global defibrillator market.Other segments which are expected to grow rapidly during the forecast period are public access and business workplace. The government initiatives for creating awareness about the usefulness of AEDs in SCA will be the crucial factor for the growth of this market. Although the FDA initiatives to tighten the AED approval process, through pre-market approval (PMA), are likely to impact the market negatively, the grace period implementing changes is considerable enough for manufacturers in the defibrillators market.

Geographically, North America is the largest market for defibrillator devices and is expected to retain its top position throughout the forecast period. The rising awareness about the SCA and defibrillators in the USA and Canada is contributing to overall growth of defibrillators market in the region. In addition, legislations requiring installation of AEDs for public access and ‘Samaritan Laws’ providing immunity to first responders are driving factors for the market.Europe was the second largest market for defibrillator devices in 2012. During the forecast period, 2013 to 2019, Asia-Pacific and Middle-East are expected to grow at a faster pace than North America and Europe owing to the large patient base, increasing incidences of cardiovascular diseases and rising per capita expenditure on healthcare. The strengthening of economies in the Asia-Pacific and the subsequent rise in the healthcare infrastructure are propelling the market for defibrillators in this region.

The global defibrillators market is dominated by few major players such as Boston Medical Corporation, Medtronic, Inc. Philips Healthcare, St. Jude Medical, Inc. and Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation).

The global defibrillators market is segmented as follows:

Global Defibrillators Market, by Product Category

  • Advanced Life Support (ALS) Defibrillators
  • Automated External Defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • Wearable Defibrillators

Global Defibrillators Market, by End-Users

  • Hospitals
  • Home
  • Public Access
  • Emergency Medical Services
  • Business Workplace

Global Defibrillators Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Middle-East
  • Latin America
  • Africa

Related & Recently Published Reports by Transparency Market Research

Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type – Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/sterilization-equipment-market.html

Sterilization equipment and disinfectants are essential procedures for infection control in healthcare facilities such as hospitals, clinics and laboratories. Increase in hospital acquired infections has compelled medical professionals to take strict regulatory actions to cure these infections with the use of various sterilization equipment and disinfectants. This factor will trigger the growth of sterilization equipment and disinfectants market during the forecast period. In addition, rise in geriatric population and increase in the number of surgeries performed at hospitals and clinics will further drive the growth of this market. The market for sterilization equipment can be segmented as: by product (heat, low temperature, radiation and filtration sterilization) and by application (life sciences, medical devices and pharmaceuticals). The disinfectants market has been segmented based on types (low, intermediate and high level, oxidizing and non-oxidizing disinfectants). The report includes market estimations in terms of revenue (USD million) for the global sterilization equipment and disinfectants market for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments and sub segments. In addition, current market trends and recent developments have been taken into consideration while determining the growth rate of the global sterilization equipment and disinfectants market. 

Market forecast in terms of value (USD million) for the period 2013 to 2019 has been provided for four major geographic regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). Detailed qualitative analysis of the factors responsible for driving and restraining the growth of the sterilization equipment and disinfectants market and future opportunities are provided in the report. PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study to help in decision making.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

 

Minimally Invasive Vertebral Compression Fracture Repair Market to Reach USD 2.82 billion by 2019: Transparency Market Research

Transparency Market Research has announced the addition of market research report on the Minimally Invasive Vertebral Compression Fracture Repair Market titled “Minimally Invasive Vertebral Compression Fracture Repair Market (Vertebroplasty and Kyphoplasty Devices) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”. According to the report, the global market for Vertebroplasty and Kyphoplasty Devices is estimated to reach a value of USD 2.82 billion in 2019 with a growth rate of 8.7% through the years 2013 to 2019. The value of this industry was about USD 1.58 billion in 2012.

Minimally Invasive Vertebral Compression Fracture Repair Market

Albany, New York, 26 March 2014: Vertebral compression fractures (VCFs) or spine fractures, as they are commonly called, are instances of a broken bone or cracked vertebrae in the spine. VCFs commonly occur in people having osteoporosis and low bone density. However, severe trauma such as accidents, sports injury or a hard fall and metastatic tumors are common reasons for VCFs.

Clinical symptoms of VCFs may include sudden onset of back pain, limited spinal mobility, increase in pain while standing or walking, disability and deformity of the vertebrae over time, eventual vertebral height loss and medical conditions like kyphosis, segmental instability and neurological complications.

Though nonsurgical ways of treating VCFs such as medication, exercises, bracing and bed rest are widely prevalent, surgical ways such as kyphoplasty and vertebroplasty have also evolved as valuable adjunctive treatment options. are also increasingly gaining popularity for treating complex cases where non-surgical methods fail to benefit.

Browse the full report PDF with TOC :Minimally Invasive Vertebral Compression Fracture Repair Market to Reach USD 2.82 billion by 2019

Kyphoplasty involve percutaneous cannulation of the vertebral fracture by placing an inflatable bone tamp (a balloon like structure) into the fracture. This helps in restoring the original height of the vertebrae, which is then injected with bone cement. Vertebroplasty, on the other hand, involves direct percutaneous injection of bone cement on the vertebral fracture.

Vertebroplasty helps in relieving pain and enhancing mobility in patients while Kyphoplasty also helps in restoring the height of the deformed vertebrae, thus assisting in the cure of kyphosis. Complication rates of less than 2 percent for osteoporotic VCFs and upto 10 percent for VCFs due to malignant tumors, patient testimonials of significant pain relief and rise in physical functioning along with  advancements in the technology used for treatment have all resulted in the popularity of these treatments over the past few decades.

However, a comparatively lower complication rate post procedure and additional benefits such as restoration of vertebral height have resulted in a higher adoption rate of kyphoplasty procedures over vertebroplasty throughout the world, particularly in North America. Considering this popularity of the procedure and its obvious advantages over vertebroplasty, its market share in the coming future is estimated to be increasing rapidly. In 2011, the global market for kyphoplasty was worth USD 555.4 million.

The international market of minimally invasive VCF repair is highly secure in nature. There only a handful of vendors that are well established and dominate the market by capturing over 80% of its share. The existence of only a few market players has resulted in an intensive competitive rivalry among the players.  The market is further characterized by activities such as acquisitions, long term supply agreements and partnerships. The major companies that dominate this market include Medtronic Inc., Cook Medical Inc., CareFusion Corporation, DFine, Inc., Zimmer Holdings, DePuySynthes Inc., among few others.

Owing to the early launch of innovative products and techniques in the US, it is no surprise that the country is the current market leader of the minimally invasive VCF repair market. Existence of factors such as high awareness about VCF conditions and the treatments available and a supportive economic base particularly in the form of well-defined medical re-imbursement policies has also proved instrumental in the growth of the minimally invasive VCF repair market in the US. However, developing economies such as China, Japan, India, Korea are observed as potentially emerging markets owing to the aging population, increase in general awareness about osteoporosis and development in healthcare facilities in these countries.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Contact:

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA/Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019 : Transparency Market Research

Nanomedicine

Transparency Market Research has announced the publication of its latest report “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”.

28 March 2014 Albany, New York, USA:

A new market research report by Transparency Market research sheds light on the growing scope of the Nanomedicine Market globally, and provides an in-depth analysis of the potential growth areas, restraints, region-wise revenue share, and much more.

The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019.

The report talks about the major growth areas of within the nanomedicine market over the period of forecast. The introduction of new technologies and applications in this sector will propel growth to a significant degree at the global level. Further, the initiatives taken by various governments as well as privately-funded institutions towards promoting the commercialization of new nanomedicine products will boost this market. The report also dwells on the role played by the rising geriatric population base, the prevalence of medical needs that are in need of treatment, as well as the rising incidence of chronic diseases globally.

According to the report, the leading application segment within the nanomedicine market was that of oncology, holding a 38% share of the overall market in 2012, as a vast number of commercially available products prevail in this sector.

The development of nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.
Browse the full report PDF with TOC : Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019

Though the largest market segment within the nanomedicine market is that of oncology, the fastest growing segment is the cardiovascular market. According to the Transparency Market Research report, growth in this segment has been fuelled by the presence of a sizeable patient population, and a simultaneous growth in the demand for device and drugs that are based on nanomedicine. These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the nanomedicine market.

The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products. According to the report, the nanomedicine market was largely dominated by North America in 2012. It is expected that this regional market will continue to hold its leading position in the way over the forecast period until 2019.

Though the larger market share will be held by North America, it is anticipated that the fastest growing market, by region, will be Asia-Pacific. The report states that the CAGR recorded by the Asia-Pacific market will be 14.6% between 2013 and 2019.

Furthermore, the analysis of the regional markets also concludes that the Europe region is predicted to show a growth rate that’s relatively higher than that of North America. Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.

The report on the global nanomedicine market additionally comprises an overview of the key market players in a section dedicated to company profiles. These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.

To browse through the entire ToC or to purchase the report titled “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, please visit http://www.transparencymarketresearch.com/nanomedicine-market.html

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Contact:

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA/Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Link

Global Biopreservation Market Expected to Reach USD 5.74 Billion Globally in 2019

Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

global-biopreservation-market-by-product-type-and-application-2012

The global biopreservation market was valued at USD 1.95billion in 2012 and is expected to reach a value of USD 5.74 billion in 2019, growing at a CAGR of 16.7% from 2013 to 2019.

Browse Biopreservation Market Report with Full TOC at http://www.transparencymarketresearch.com/biopreservation-market.html

Extensive undertaking of biomedical research for new drugs and therapies will be one of the major factors responsible for growth of the global biopreservation market. Use of stem cells, tissues, plasma and DNA in the research sector also requires adequate storage facilities to accommodate the growing number of samples, while also maintaining their stability. Increase in sample size will lead to rise in demand for equipment such as freezer, refrigerator, liquid nitrogen and consumables, along with media and laboratory information management systems (LIMS).In addition, increase in funding aimed at boosting the capacity for sample storage by the government as well as private institutions will expedite the introduction of new biopreservation facilities and hence will drive growth of the overall market. Other driving factors include rising incidences of cardiovascular, orthopedic, oncological, autoimmune and infectious diseases, rising population awarenessand increase in the number of individual sample contributions.
Browse the full report PDF with TOC :Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The global biopreservation market by product type was dominated by the equipment segment with a market share of approximately 82% in 2012,on account of thehigh cost and demand from biobanks and in-house preservation facilities of pharmaceutical and biotechnology companies. Increase in the sample size will also result in the need for capacity expansion and so will lead to increase in demand for biopreservation equipment. However, the global market for biopreservation consumables will be the fastest growing product segment. Factors such as increased research and transnational activities will have a high demand for biological samples, which would also increase the demand for media solutions. The home-brew media segment held the majority share of over 72%in the total market for biopreservation media in 2012.

The global biopreservation market by applications was dominated by the biobanking segment with a market share of approximately 72% in 2012 on account of thehigh demand and usage of equipment, media and LIMS in this segment. Establishment of new biobanks during the forecast period will be one of the major growth factors for the biobanking application segment.However, the global regenerative medicine market for biopreservation will be the fastest growing application segment. A factor such as high prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cardiac disorders and tumors is driving the regenerative medicine market which will result in increased demand for biopreservation media and equipment.

North America dominated the biopreservation market in 2012 and is expected to maintain its position till 2019. However, the Asia-Pacific market is estimated to grow at a faster CAGR of 19.6% from 2013 to 2019, due to increase in biobanking and research activities in the region. The European market is expected to grow at a fairly higher rate than North America,on account of the constantly improving infrastructure, regulatory framework and new biobanking projects, especially in the Eastern European region.

Some of the key players in the global biopreservation market include Thermo Fisher Scientific Inc., VWR International LLC, BioLife Solutions Inc., BioCision LLC, Biomatrica Inc., Qiagen, LABVANTAGE Solutions Inc. and Panasonic Corporation.

The global biopreservation market is categorized into the following segments:

Biopreservation Market, by Product Type

Equipment

  • Freezers
  • Refrigerators
  • Liquid Nitrogen Tanks
  • Consumables
  • Laboratory Information Management Systems(LIMS)
  • Media

Biopreservation Market, by Application

  • Regenerative Medicine
  • Biobanking
  • Drug Discovery

Biopreservation Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse all Medical Devices Market Research Reports Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Link

Minimally Invasive Vertebral Compression Fracture Repair Market Expected to Reach USD 2.82 Billion Globally in 2019: Transparency Market Research

Minimally Invasive Vertebral Compression Fracture Repair Market (Vertebroplasty and Kyphoplasty Devices) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

tmr-160x160

The global minimally invasive vertebral compression fracture repair market was valued at USD 1.58 billion in 2012 and is expected to grow at a CAGR of 8.7%from 2013 to 2019, to reach an estimated value of USD 2.82 billion in 2019.

Browse Minimally Invasive Vertebral Compression Fracture Repair Market Report with Full TOC athttp://www.transparencymarketresearch.com/vertebral-compression-fracture-repair.html

Minimally invasive vertebral compression fracture (VCF) repair is one of the fastest growing segments in the overall spinal surgeries market. Factors such as growth in incidence of vertebral compression fractures, high prevalence of osteoporosis, aging of population worldwide and inability of medicinal therapy to cure vertebral compression fracture to the optimum level will have an impact on the growth of the minimally invasive vertebral compression fracture repair industry.

The global minimally invasive vertebral compression fracture repair market is segmented on the basis of types of procedural technology and geography. Based on technology, the minimally invasive VCF repair market is classified into vertebroplasty and kyphoplasty devices. It is expected that the global market for kyphoplasty will reach USD 1.47 billion in 2019 growing at a CAGR of 11.7% from 2013 to 2019.

Browse the full report PDF with TOC : Minimally Invasive Vertebral Compression Fracture Repair Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The United States currently leads the minimally invasive VCF repair market, owing to the early bird advantage rendered by the first launch of innovative products in the country. Growth drivers in the North American minimally invasive VCF repair market include existence of well-defined reimbursement policies, supportive economic base particularly in terms of medical reimbursement, high awareness about VCF conditions and the treatments available. However, countries such as China, Japan, Korea, Australia and India are observed to be potentially emerging markets with higher aging population, development of healthcare infrastructure, high prevalence of osteoporosis and rise in general awareness about healthcare. Countries such as Brazil, Mexico and Argentina are some of the lucrative markets in the Rest of the World.

The global minimally invasive VCF repair market is highly consolidated in nature with companies like Medtronic, Inc. dominating the market with more than 80% of the market share. Some of the other key market players operating in this market include Alphatec Spine, Inc., CareFusion Corporation, Cook Medical, Inc., DFine, Inc., Zimmer Holdings, Globus Medical, Inc. and DePuySynthes, Inc.

The global minimally invasive VCF repair market is segmented as follows:

Minimally Invasive Vertebral Compression Fracture Repair Market, by Technology

  • Vertebroplasty
  • Kyphoplasty

Minimally Invasive Vertebral Compression Fracture Repair Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Related & Recently Published Reports by Transparency Market Research

Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/biopreservation-market.html

This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets.

The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million.
The biopreservation market, by products is segmented into equipment, laboratory information management systems (LIMS) and media. The market for equipment is further analyzed as freezers, refrigerators, liquid nitrogen tanks and consumables. In addition, the media market is segmented into two types of formulations as home-brew media and pre-formulated media.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Browse all Medical Devices Market Research Reports Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Link

Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Blood Flow Measurement Devices Market Expected to Reach USD 0.50 Billion Globally in 2019: Transparency Market Research

global-blood-flow-measurement-devices-market-2012

 

According to a new market report published by Transparency Market Research Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019 the global blood flow measurement devices market was valued at USD 0.27 billion in 2012 and expected to grow at a CAGR of 8.7% from 2013 to 2019, to reach an estimated value of USD 0.50 Billion in 2019.

Browse Blood Flow Measurement Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/blood-flow-measurement-devices.html

Blood flow measurement devices are primarily used for measurement of volume rate of blood flow for diagnosis of disorders and diseases. The volume rate of blood flow is defined as the amount of blood passing through a cross section of a blood vessel per unit time. Rise in incidence rate of individuals suffering peripheral vascular diseases and growing geriatric population are some of the factors fuelling the growth of this market. According to the statistical data provided by the Centers for Disease Control and Prevention (CDC) in the year 2012, approximately 8,000,000 people in the United States were diagnosed with peripheral arterial disease; that includes 12-20% of population older than 60 years of age. Similarly, increasing clinical applications of blood flow devices is another factor which is likely to trigger the market growth.

Transparency Market Research

Blood flow measurement devices have a wide range of clinical applications varying from diabetes, dermatology, tumor monitoring, intra cranial monitoring, gastroenterology to peripheral vascular diseases. Among all of the above mentioned clinical applications, peripheral vascular diseases accounted for the largest market share (approximately 27.8%) in 2012. Moreover, the disease is expected to show the highest growth rate reporting a CAGR of 11.3% during the forecast period 2013-2019. The growth in this segment is attributed to rise in the number of obese population coupled with the increasing risk of cardiovascular and circulatory diseases. Intra-cranial monitoring and tumor monitoring are also expected to witness significant growth during the forecast period.

Ultrasonic Doppler blood flow meters accounted for the largest share of the market in 2012 and are poised to grow at a CAGR of 10.7% from 2013-2019. This growth rate is anticipated owing to innovations in technology and rise in the number of clinical applications. Moreover, recent developments in Ultrasonic Doppler blood flow meters such as digital Doppler, multi-range Doppler technology and bilateral Doppler technology has paved a new path for the growth of this market. In addition, factors such as development of minimally invasive and non-invasive devices as well as rigorous R&D initiatives are expected to drive the global blood flow measurement devices market. Laser Doppler blood flow meter devices market is expected to decline due to high cost and a gradual decline in the number of clinical applications as compared to ultrasonic Doppler blood flow meters.

Browse the full report PDF with TOC : Blood Flow Measurement Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

In terms of geography, North America is the leading geography for blood flow measurement devices market owing to rise in circulatory disorders and escalated health awareness. Emerging economies such as Latin America and Asia are expected to display significant growth prospects for the blood flow measurement devices market. Countries such as China, Russia, Brazil and India are expected to foresee a high growth for blood flow measurement devices owing to a large base of diabetic and geriatric population coupled with high prevalence of peripheral arterial diseases in these countries. However, stringent regulatory approvals coupled with high shipment costs of these devices could hinder market growth.

Some of the major companies involved in the production and commercialization of blood flow measurement devices are ArjoHuntleigh Inc., Deltex Medical, Transonic Systems Inc., Moor Instruments Ltd. and Cook Medical Inc., amongst others.

The global blood flow measurement devices market is segmented as follows:

Blood Flow Measurement Devices Market, by Product types

  • Ultrasonic Doppler Blood Flowmeters
  • Laser Doppler Blood Flowmeters
  • Electromagnetic Blood Flowmeters

Blood Flow Measurement Devices Market, by Applications

  • Gastroenterology
  • Diabetes Research
  • Dermatology
  • Peripheral Vascular Diseases
  • Intra-cranial Monitoring in Stroke and Brain Injury

Blood Flow Measurement Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related & Recently Published Report by Transparency Market Research

Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.

The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders, oncology, HLA testing and pharmacogenetics testing. The infectious diseases segment comprises market for HIV infections, HAI, HCV infections and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.